REQUEST A DEMO
Total
USD $0.00
Search more companies

Sedarte Medicina Especializada S.A.S. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Diagnostic Imaging Centers
Full name: Sedarte Medicina Especializada S.A.S. Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sedarte Medicina Especializada S.A.S. is an enterprise in Colombia, with the main office in Sincelejo. The enterprise currently operates in the General Medical and Surgical Hospitals sector. It was first established on September 15, 2014. The company’s latest financial report indicates a net sales revenue increase of 130.45% in 2023. There was a total growth of 134.62% in Sedarte Medicina Especializada S.A.S.’s total assets over the same period. The net profit margin of Sedarte Medicina Especializada S.A.S. increased by 14.96% in 2023.

Headquarters
Cr 16 16 136
Sincelejo; Sucre;

Contact Details: Purchase the Sedarte Medicina Especializada S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Sedarte Medicina Especializada S.A.S. report to view the information.
Incorporation Date:
September 15, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Sedarte Medicina Especializada S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
130.45%
Total operating revenue
130.45%
Operating profit (EBIT)
186.12%
Net Profit (Loss) for the Period
386.02%
Total assets
134.62%
Total equity
232.66%
Operating Profit Margin (ROS)
6.09%
Net Profit Margin
14.96%
Return on Equity (ROE)
19.49%
Debt to Equity Ratio
-5.61%
Quick Ratio
-0.89%
Cash Ratio
-0.38%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?